Biotechnology
| Wed 17 Jun 2026
Taipei, June 18 -- Gilead Sciences has submitted a patent application for Sars-cov2 Main Protease Inhibitors. This invention was developed by Cai Xin-pei, Chang Weng K, Canales Eda Y, Kinfe Henok H, Naduthambi Devan, Schroeder Scott D, Ammann Stephen E, Rodriguez Kevin X and Swank Christopher J.
The patent application number is..